Riskpilot← Back to searchSign inGet full accessMEDORAL AS
ASActiveOrg 914507693Martin Stokkens Veg 49, 7027 TrondheimDental practice care activities · NACE 8623Est. 20141 employees
Revenue 2025
NOK 3,3M
+77% vs 2024
EBITDA margin
91.4%
+92% vs 2024
Equity ratio
3.6%
Financial strength
Net profit 2025
NOK 2,4M
+91% vs 2024
| Revenue | NOK 3,3M | +77% |
| EBITDA | NOK 3M | +92% |
| Net profit | NOK 2,4M | +91% |
| Total assets | NOK 3,2M | +80% |
| Equity | NOK 116K | +44% |
| Employees | 1 | — |
Legal name
MEDORAL AS
Org number
914507693
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
24. november 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Levere maxillofacial kirurgiske og oralkirurgiske tjenester og andre produkter/tjenester som naturlig hører sammen med dette, herunder delta i andre selskap med lignende virksomhet og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Martin Stokkens Veg 49, 7027 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 453 | 1 592 | 1 750 | 1 860 | 3 297 |
| Staff expenses | −139 | −139 | −139 | −139 | −144 |
| EBITDA | 1 180 | 1 322 | 1 472 | 1 571 | 3 014 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 180 | 1 322 | 1 472 | 1 571 | 3 014 |
| Net financials | 2 | −166 | 30 | 28 | 45 |
| Profit before tax | 1 182 | 1 156 | 1 502 | 1 600 | 3 059 |
| Tax | 263 | 296 | 334 | 353 | 674 |
| Net profit | 919 | 860 | 1 168 | 1 247 | 2 385 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 247 | 2 144 | 1 743 | 1 758 | 3 166 |
| Equity | 955 | 216 | 134 | 80 | 116 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 291 | 1 928 | 1 609 | 1 678 | 3 051 |
| Total debt | 291 | 1 928 | 1 609 | 1 678 | 3 051 |
EBITDA margin
91.4%
This company
15.8%
Market median
+478% vs market
20212025
Equity ratio
3.6%
This company
38.2%
Market median
-91% vs market
20212025
Return on equity
2065.0%
This company
18.4%
Market median
+11123% vs market
20212025
Net profit margin
72.3%
This company
8.1%
Market median
+793% vs market
20212025
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
26.41×
This company
0.62×
Market median
-4160% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AN Chief Executive Officer | Chief Executive Officer | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDORAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Attila Nagy | Chief Executive Officer | 0 companies |